Acknowledged as a privileged partner by the pharmaceutical industry for nearly 30 years, ICTA offers among a wide range of clinical R&D services the set of requisites necessary for a full-service in clinical R&D, epidemiology, pharmaco-economics and management of early access programs.

Today, ICTA is one of the rare European CROs able to provide a reliable expertise based on a concrete experience in both traditional (national and international Phase I/II/III studies) and modern (Bayesian, frequentist adaptive and seamless) clinical trials.

To take up your clinical challenges, we offer an organization coupled with human, logistic and computer means suited to the needs of new adaptive studies where anticipation, operating security, flexibility and responsiveness are key words.

Because your expectations are our concern, discover our organization and expertise to manage complex situations.